Validation of Dried Blood Spots for Detection of Antibodies to Treponema Pallidum

Overview

About this study

The purpose of this research is to validate new testing methods for diagnosing patients with Treponema pallidum (syphilis).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

Subjects who are ≥ 18 years of age.
Subjects who are known to be positive for syphilis antibodies using routine, standard of care serologic assays.

Exclusion Criteria:

Subjects who are < 18 years of age.
Subjects who are unable to give informed consent.

Eligibility last updated 11/19/21. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status	Contact
Rochester, Minn. Mayo Clinic principal investigator Elitza Theel, Ph.D.	Open for enrollment	Contact information: Autumn Grover (507) 422-9879 Grover.Autumn@mayo.edu

Mayo Clinic Location

Status

Contact

Rochester, Minn.

Mayo Clinic principal investigator

Elitza Theel, Ph.D.

Open for enrollment

Contact information:

Autumn Grover

(507) 422-9879

Grover.Autumn@mayo.edu

More information

Publications

Publications are currently not available

Clinical Trials